ITGAX and pancreatic neoplasm: The levels of adrenate (22:4n6) were found to negatively modulate pancreatic cancer concerning CD11c+ monocyte %monocyte (Mediated effect, ME=-0.00837; Mediated proportion, MP=-8.39%) (Table 2).